Wilmington, N.C.-based Trans1, a company that produces medical devices in the spine sector with focus in the lower lumbar region, has appointed a new member to its board of directors. Jeffrey Fischgrund, M.D., joins the company with more than 20 years of experience in orthopedic surgery, and will continue to serve as professor of orthopedic surgery at the Oakland University School of Medicine at William Beaumont Hospital in Royal Oak, Mich.
Fischgrund earned his medical degree at George Washington University School of Medicine in Washington, D.C. He then went on to complete an orthopedic surgery residency at the University of Maryland Medical Center in Baltimore, Md., and a spine surgery fellowship at William Beaumont Hospital. He has served as the editor in chief of the Journal of the American Academy of Orthopaedic Surgeons since 2009, and has been the spine fellowship director at Beaumont since 2008. He is also a member of the American Academy of Orthopaedic Surgeons, Michigan Orthopaedic Society, Michigan State Medical Society, Oakland Count Medical Society, Detroit Academy of Orthopaedic Surgeons, and the Spine Study Group.
Fischgrund pursues research interests in spinal surgery and has a particular research interest in bone morphogenetic proteins (BMPs) and cervical disc replacements.